AGR2 facilitates teratoma progression by regulating glycolysis via the AnXA2/EGFR axis

被引:0
|
作者
Zhang, Yahong [1 ]
Zhang, Jing [2 ]
机构
[1] Baoji Peoples Hosp, Dept Gynecol, 24 Xinhua Lane,Jinger Rd, Baoji 721000, Shaanxi, Peoples R China
[2] Baoji Cent Hosp, Dept Gynecol, 8 Jiangtan Rd, Baoji 721008, Shaanxi, Peoples R China
关键词
Teratomas; Glycolysis; AGR2; AnXA2/EGFRaxis; Warburg effect; GROWTH-FACTOR RECEPTOR; CELL-PROLIFERATION; CANCER; OVEREXPRESSION; PROTEIN; INHIBITION; PHENOTYPE; MIGRATION; INVASION; MARKER;
D O I
10.1016/j.yexcr.2024.114228
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Anterior gradient-2 (AGR2) is highly expressed in several tumors and plays an important role in tumor development. However, the biological function of AGR2 in teratomas has not yet been thoroughly studied. In this study, AGR2 was found to be upregulated in teratoma tissues and in human testicular teratoma cell lines by Western blotting and qRT-PCR assays. A DNA Methylation-Specific PCR assay demonstrated that AGR2 upregulation resulted from hypomethylated AGR2 in teratoma cells. NCC-IT and NT2-D1 cells were transfected with pcDNA-AGR2 or sh-AGR2 to obtain AGR2-overexpressed or-silenced cells, and cell proliferation, invasion and glycolysis were determined using CCK-8, 5-ethynyl-2 '-deoxyuridine '-deoxyuridine (EdU), Transwell assays, and commercial kits. The results revealed that overexpression of AGR2 promoted teratoma cell proliferation and invasion and elevated glycolysis levels evidencing by the increase in lactate secretion, glucose consumption, ATP levels and the expression of glycolysis-related proteins, while knockdown of AGR2 showed the opposite results. The interactions between AGR2 and annexin A2 (AnXA2), as well as between AnXA2 and epidermal growth factor receptor (EGFR) were verified by co-immunoprecipitation assay. Mechanistic studies revealed that AGR2 interacts with AnXA2 and increases the level of AnXA2 to recruit more AnXA2 to EGFR, there by promoting EGFR expression. A series of rescue experiments showed that knockdown of AnXA2 or EGFR weakened the promotional effects of AGR2 overexpression on the proliferation, invasion, and glycolysis of teratoma cells. Finally, tumorigenicity assays were performed using NT2-D1 cells stably transfected with either LV-NC-shRNA or LV-shAGR2. The results showed that AGR2 knockdown significantly inhibited teratoma tumor growth in vivo. . In conclusion, our data suggested that AGR2 facilitates glycolysis in teratomas through promoting EGFR expression by interacting with AnXA2, thereby promoting teratoma cells proliferation and invasion.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Nuclear autoantigenic sperm protein facilitates glioblastoma progression and radioresistance by regulating the ANXA2/STAT3 axis
    Qiu, Yuning
    Pei, Dongling
    Wang, Minkai
    Wang, Qimeng
    Duan, Wenchao
    Wang, Li
    Liu, Kehan
    Guo, Yu
    Luo, Lin
    Guo, Zhixuan
    Guan, Fangzhan
    Wang, Zilong
    Xing, Aoqi
    Liu, Zhongyi
    Ma, Zeyu
    Jiang, Guozhong
    Yan, Dongming
    Liu, Xianzhi
    Zhang, Zhenyu
    Wang, Weiwei
    CNS NEUROSCIENCE & THERAPEUTICS, 2024, 30 (04)
  • [2] AGR2 is associated with gastric cancer progression and poor survival
    Zhang, Jun
    Jin, Yongming
    Xu, Shaonan
    Zheng, Jiayin
    Zhang, Qi
    Wang, Yuanyu
    Chen, Jinping
    Huang, Yazeng
    He, Xujun
    Zhao, Zhongsheng
    ONCOLOGY LETTERS, 2016, 11 (03) : 2075 - 2083
  • [3] ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis
    Sai Ma
    Chen-Chen Lu
    Li-Yan Yang
    Juan-Juan Wang
    Bo-Shi Wang
    Hong-Qing Cai
    Jia-Jie Hao
    Xin Xu
    Yan Cai
    Yu Zhang
    Ming-Rong Wang
    Journal of Experimental & Clinical Cancer Research, 37
  • [4] ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis
    Ma, Sai
    Lu, Chen-Chen
    Yang, Li-Yan
    Wang, Juan-Juan
    Wang, Bo-Shi
    Cai, Hong-Qing
    Hao, Jia-Jie
    Xu, Xin
    Cai, Yan
    Zhang, Yu
    Wang, Ming-Rong
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37
  • [5] ANXA2 enhances the progression of hepatocellular carcinoma via remodeling the cell motility associated structures
    Shi, Hongyan
    Xiao, Li
    Duan, Wei
    He, Huimin
    Ma, Lele
    Da, Miaomiao
    Duan, Yan
    Wang, Qian
    Wu, Huayi
    Song, Xigui
    Hou, Yingchun
    MICRON, 2016, 85 : 26 - 33
  • [6] Nectin2 influences cell apoptosis by regulating ANXA2 expression in neuroblastoma
    Zhang, Shihan
    Jiang, Chiyi
    Su, Yan
    Gui, Jingang
    Yue, Zhixia
    Jian, Binglin
    He, Sidou
    Ma, Xiaoli
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2023, 55 (03): : 356 - 366
  • [7] Annexin A2 (AnxA2) association with the clinicopathological data in different breast cancer subtypes: A possible role for AnxA2 in tumor heterogeneity and cancer progression
    Abdelraouf, Esraa Magdy
    Hussein, Raghda R. S.
    Shaaban, Ahmed Hassan
    El-Sherief, Hany A. M.
    Embaby, Azza S.
    El-Aleem, Seham A. Abd
    LIFE SCIENCES, 2022, 308
  • [8] NNMT promotes the progression of intrahepatic cholangiocarcinoma by regulating aerobic glycolysis via the EGFR-STAT3 axis
    Lu, Shounan
    Ke, Shanjia
    Wang, Chaoqun
    Xu, Yanan
    Li, Zihao
    Song, Keda
    Bai, Miaoyu
    Zhou, Menghua
    Yu, Hongjun
    Yin, Bing
    Li, Xinglon
    Feng, Zhigang
    Hua, Yongliang
    Pan, Shan ha
    Jiang, Hon Chi
    Li, Linqiang
    Wu, Yaohua
    Ma, Yong
    ONCOGENESIS, 2022, 11 (01)
  • [9] NNMT promotes the progression of intrahepatic cholangiocarcinoma by regulating aerobic glycolysis via the EGFR-STAT3 axis
    Shounan Lu
    Shanjia Ke
    Chaoqun Wang
    Yanan Xu
    Zihao Li
    Keda Song
    Miaoyu Bai
    Menghua Zhou
    Hongjun Yu
    Bing Yin
    Xinglong Li
    Zhigang Feng
    Yongliang Hua
    Shangha Pan
    Hongchi Jiang
    Linqiang Li
    Yaohua Wu
    Yong Ma
    Oncogenesis, 11
  • [10] Inhibition of AGR2 by RNA interference suppresses progression in colorectal carcinoma
    Gao, Hua
    Xu, Xincai
    Wang, Feng
    Zhang, Wenbing
    Wang, Yunhai
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 710 - 711